Pura Vida Investments, LLC Coherus Bio Sciences, Inc. Call Options Transaction History

Pura Vida Investments, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2019 Feb 14, 2020	SELL	$16.33 - $21.37 $6.53 Million - $8.55 Million	-400,000 Closed	0 $0
Q3 2019 Feb 12, 2021	BUY	$16.3 - $23.37 $6.45 Million - $9.25 Million	396,000 Added 9900.0%	400,000 $8.1 Million
Q3 2019 Nov 14, 2019	SELL	$16.3 - $23.37 $749,800 - $1.08 Million	-46,000 Reduced 92.0%	4,000 $290,000
Q1 2018 Feb 11, 2021	BUY	$9.1 - $13.7 $450,450 - $678,150	49,500 Added 9900.0%	50,000 $553,000
Q1 2018 May 14, 2018	SELL	$9.1 - $13.7 $450,450 - $678,150	-49,500 Reduced 99.0%	500 $0
Q4 2017 Feb 11, 2021	BUY	$8.35 - $14.4 $417,500 - $720,000	50,000	50,000 $440,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $57.5M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.